Tuberculosis Infection in HIV-Infected Indian Patients

AIDS Patient Care and STDs

Volumn 18, Issue 4, 2004, Pages 209-213

  Vajpayee, Madhu ^a   Kanswal, Sunita ^a   Seth, Pradeep ^a   Wig, Navneet ^a   Pandey, R M ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; CD4 LYMPHOCYTE COUNT; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; COMORBIDITY; FEMALE; HIV INFECTIONS; HUMANS; INDIA; MALE; RETROSPECTIVE STUDIES; TUBERCULOSIS;

EID: 2142808326     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/108729104323038883     Document Type: Article

References (27)

1. Sunderam G, McDonald RJ, Maniatatis T, Oleske J, Kapila R, Reichman IB. Tuberculosis as a manifestation of the acquired immunodeficiency syndrome (AIDS) JAMA 1986;256:362-366.
2. Theurer CP, Hopewell PC, Ellias D, Schecter GF, Rutherford GW, Chaisson RE. Human immunodeficiency virus infection in tuberculosis patients. J Infect Dis 1990;162:8-12.
3. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992;41:1-19.
4. Raviglione MC, Narain JP, Kochi. Global epidemiology of tuberculosis: Morbidity and mortality of a worldwide epidemic. JAMA 1995;273:220-226.
5. Shafer RW, Edlin BR. Tuberculosis in patients infected with human immunodeficiency virus: Perspective on the past decade. Clin Infect Dis 1996;22:683-704.
6. World Health Organization. The current global situation on the HIV/AIDS pandemic. Wkly Epidemol Rec 1995;70:353-357.
7. Davidow AL, Mangura BT, Napolitano EC, Reichman LB. Rethinking the socioeconomics and geography of tuberculosis among foreign-born residents of New Jersey, 1994-1999. Am J Public Health 2003;93: 1007-1012.
8. Del Amo J, Malin AS, Pozniak A, De Cock KM. Does tuberculosis accelerate the progression of HIV disease? Evidence from basic science and epidemiology AIDS 1999;13:1151-1158.
9. Barnes PF, Bloch AB, Davidson PT, Snider DE. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991;324:1644-1650.
10. Fahey JL, Taylor JMG, Detels R. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type I. N Engl J Med 1990;322:166-172.
11. National AIDS Control Organization (NACO). (1986-1999), Ministry of Health and Family Welfare, Government of India, Surveillance for HIV Infection/AIDS Cases in India. pp. 220-226.
12. Bhatia RS. Tuberculosis and acquired immunodeficiency syndrome. J Assoc Physicians India 2000;48: 613-616.
13. Sudre P, ten Dam G, Kochi A. Tuberculosis a global overview of the situation today. Bull WHO 1992;70: 140-159.
14. Schurmann D, Ruf B, Mauch H, Pohle HD. Tuberculosis in HIV infection: therapy and outcome. Am Rev Respir Dis 1990;140(Suppl A):267.
15. Laguna F, Adrados M, Diaz F. AIDS and tuberculosis in Spain: A report of 140 cases. J. Infect 1991;23: 139-144.
16. Dolin P, Raviglione MC, Kochi A. Global tuberculosis incidence and mortality. Bull WHO 1994;72:213-220.
17. Phillips AN, Lee CA, Elford J. Serial CD4 lymphocyte counts and development of AIDS. Lancet 1991;337: 389-392.
18. Crowe SM, Carlin JB, Stewart KI, Lucas CR, Hoy JF. Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV infected persons. J Acquir Immune Defic Syndr 1991;4:770-776.
19. Ackah AN, Coulibaly D, Digbeu H, et al. Response to treatment, mortality, and CD4 lymphocyte counts in HIV infected persons with tuberculosis in Abidjan Cote d' Ivoire. Lancet 1995;345:607-610.
20. Mukadi Y, Perriens JH, St Louis ME, et al. Spectrum of immunodeficiency in HIV-1 infected patients with pulmonary tuberculosis in Zaire. Lancet 1993;342: 143-146.
21. + T-lymphocyte values in different HIV-infected populations. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:185-186.
22. Kramalingam S, Kannangai R, Zachariah A, Mathai D, Abraham OC. CD4 counts of normal and HIV-infected south Indian Adults: Do we need a new staging system? Nat Med J Ind 2001;14:335-339.
23. Raviglione MC, Narain JP, Kochi A. HIV-associated tuberculosis in developing countries: Clinical features, diagnosis, and treatment. Bull World Health Organ 1992;70:515-526.
24. Jones BE, Young SMM, Antoniskis D, Davidson PT, Kramer F, Barnes PF. Relationship of the manifestation of tuberculosis to CD4 counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis 1993;148:1292-1297.
25. Morris L, Martin DJ, Bredell H, et al. Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts during treatment for active tuberculosis, in South African patients. J Infect Dis 2003;187: 1967-1971.
26. Del Amo J, Perez-Hoyos S, Hernandez Aguado I, Diez M, Castilla J, Porter K; Concerted Action on Seroconversion to AIDS and Death in Europe (CASCADE) Collaboration. Impact of Tuberculosis on HIV disease progression in persons with well documented-time of HIV seroconversion. J Acquir Immune Defic Syndr 2003;33:184-190.
27. Martin DJ, Sim JGM, Sole GJ, et al. CD4 lymphocyte counts in African patients co-infected with HIV and tuberculosis. J Acquir Immune Defic Syndr Hum Retroviruses 1995;8:386-391.